BSE Live
Jan 02, 15:31Prev. Close
73.59
Open Price
73.01
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 02, 15:31Prev. Close
73.02
Open Price
71.25
Bid Price (Qty.)
72.69 (44)
Offer Price (Qty.)
73.58 (6)
| Profit & Loss account of Bal Pharma (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| INCOME | |||
| Revenue From Operations [Gross] | 57.99 | 60.47 | |
| Less: Excise/Sevice Tax/Other Levies | 3.97 | 3.73 | |
| Revenue From Operations [Net] | 54.02 | 56.73 | |
| Total Operating Revenues | 54.02 | 56.73 | |
| Other Income | 0.10 | 0.01 | |
| Total Revenue | 54.12 | 56.74 | |
| EXPENSES | |||
| Cost Of Materials Consumed | 26.37 | 26.38 | |
| Purchase Of Stock-In Trade | 6.68 | 8.19 | |
| Operating And Direct Expenses | 0.91 | 0.66 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -4.87 | -2.06 | |
| Employee Benefit Expenses | 8.79 | 7.28 | |
| Finance Costs | 2.25 | 2.14 | |
| Depreciation And Amortisation Expenses | 0.90 | 0.77 | |
| Other Expenses | 10.53 | 10.16 | |
| Total Expenses | 51.76 | 53.72 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2.36 | 3.02 | |
| Exceptional Items | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 2.36 | 3.02 | |
| Tax Expenses-Continued Operations | |||
| Current Tax | 0.17 | 0.22 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | |
| Deferred Tax | 0.56 | 0.49 | |
| Tax For Earlier Years | 0.00 | 0.00 | |
| Total Tax Expenses | 0.73 | 0.71 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1.62 | 2.31 | |
| Profit/Loss From Continuing Operations | 1.32 | 2.11 | |
| Profit/Loss For The Period | 1.32 | 2.11 | |
| OTHER ADDITIONAL INFORMATION | |||
| EARNINGS PER SHARE | |||
| Basic EPS (Rs.) | 2.02 | 3.68 | |
| Diluted EPS (Rs.) | 2.02 | 3.68 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | |||
| Imported Raw Materials | 7.27 | 6.12 | |
| Indigenous Raw Materials | 13.24 | 14.30 | |
| STORES, SPARES AND LOOSE TOOLS | |||
| Imported Stores And Spares | 0.07 | 0.00 | |
| Indigenous Stores And Spares | 0.62 | 0.35 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |||
| Equity Share Dividend | 0.78 | 0.86 | |
| Tax On Dividend | 0.15 | 0.18 | |
| Equity Dividend Rate (%) | 8.00 | 15.00 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y